Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
23:00:02 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 85.15 USD | -0.05% |
|
-0.68% | -0.12% |
| 03:21pm | JPMorgan Adjusts Price Target on Edwards Lifesciences to $105 From $100, Keeps Overweight Rating | MT |
| 10-02 | Edwards Lifesciences Says US FDA Approves AUTUS Pediatric Pulmonary Valve | MT |
| Market Cap | 49.1B 43.63B 40.72B 37.11B 70B 4,720B 70.65B 493B 191B 2,413B 184B 180B 7,745B | P/E 2026 * |
33.7x | P/E 2027 * | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 45.47B 40.4B 37.71B 34.37B 64.82B 4,371B 65.43B 456B 177B 2,235B 171B 167B 7,172B | EV / Sales 2026 * |
6.73x | EV / Sales 2027 * | 5.91x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Tradegate
| EWL | Real-time | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Xetra
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -0.05% | ||
| 1 week | -0.68% | ||
| Current month | -1.36% | ||
| 1 month | -6.16% | ||
| 3 months | -7.44% | ||
| 6 months | +4.79% | ||
| Current year | -0.12% |
| 1 week | 84.48 |  | 88.19 |
| 1 month | 83.81 | | 91.53 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/14/26 A | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 A | Tax | Controller/Auditor | -253 | 0.0000% | ||
| 9/11/26 A | Tax | Executive/Senior Manager | -398 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.05% | -0.68% | +11.58% | +22.91% | 49.1B | |
| +0.35% | -3.48% | +23.38% | +29.36% | 241B | |
| +1.09% | -4.34% | +0.55% | -13.72% | 149B | |
| -2.32% | -1.89% | -10.52% | +34.10% | 142B | |
| -1.46% | -4.66% | -55.56% | -19.32% | 62.65B | |
| +0.66% | +1.75% | -18.23% | -21.12% | 47.13B | |
| +0.66% | -2.93% | +21.07% | +50.04% | 46.99B | |
| -3.05% | -0.55% | -6.80% | +34.35% | 45.65B | |
| -0.08% | -1.18% | +32.96% | +55.07% | 41.81B | |
| +2.75% | -0.31% | +167.01% | +98.89% | 40.12B | |
| Average | +0.06% | -0.04% | +16.54% | +27.06% | 86.53B | |
| Weighted average by Cap. | +0.38% | +0.29% | +10.65% | +21.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.01B 5.61B 5.11B 9.64B 650B 9.73B 67.84B 26.29B 332B 25.38B 24.83B 1,066B | 7.43B 6.6B 6.16B 5.62B 10.59B 714B 10.69B 74.55B 28.89B 365B 27.89B 27.29B 1,172B |
| Net income | 1.44B 1.28B 1.19B 1.08B 2.05B 138B 2.06B 14.4B 5.58B 70.53B 5.39B 5.27B 226B | 1.9B 1.69B 1.57B 1.43B 2.7B 182B 2.73B 19.03B 7.38B 93.21B 7.12B 6.97B 299B |
| Net Debt | -3.63B -3.23B -3.01B -2.74B -5.18B -349B -5.22B -36.44B -14.12B -178B -13.63B -13.34B -573B | -5.19B -4.62B -4.31B -3.93B -7.41B -499B -7.47B -52.13B -20.2B -255B -19.5B -19.08B -819B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | $85.15 | -0.05% | 2,401,119 |
| 01/10/26 | $85.19 | -1.31% | 3,084,782 |
| 30/09/26 | $86.32 | -2.00% | 4,893,869 |
| 29/09/26 | $88.08 | +1.44% | 3,383,130 |
| 28/09/26 | $86.83 | +0.63% | 3,228,053 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
